RE:Wedbush Analyst Report
Stay patient Nohandle, although it's far easier to remain patient when you know what's going to happen, I believe the stability of the BoD and their slow accumulation of options and shares is important. This company is LOADED with top end talent ( see Chairman - former CEO of Siemans Global Diagnostics ). In addtion to their track record, they are seasoned ( polite way of saying, "they're entering the twi-lite of their career" ) I don't think they hang around a "One Trick Pony" like this company if they weren't super confident in their ability to succeed.
Wedbush is a first class organization and I'd be shocked if they flogged a .50 ( Canadian company ) without confirmation from the FDA that the trial was on track for success. I believe this is the "real bottom" of the share price, the previous action in the high teens and .20's was just plain ridiculous, and anybody with half a brain would understand the benefit of that action. Stick with it, if the FDA gives a "thumbs up", Wedbush will put the report to VERY GOOD use, like perhaps on their "Best Ideas List"...google that one, and you'll soon see why this share price is really just like a warrant at these prices. Inclusion on the "Best Idea's List" would send us all to places we never thought we'd be....like retired.
schemer